Brain Hemorrhage: 2018 Pipeline Insight Report - Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com
Sep. 11, 2018
DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Brain Hemorrhage - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Hemorrhage development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
ScopeThe report provides a snapshot of the pipeline development for the Brain Hemorrhage The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Brain Hemorrhage The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Brain Hemorrhage The report also covers the dormant and discontinued pipeline projects related to the Brain Hemorrhage
Companies FeaturedAngioChem Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Cavion LLC Celldex Therapeutics Inc. F. Hoffmann-La Roche Ltd. Ipsen SA Millennium Pharmaceuticals Inc. Northwest Biotherapeutics Inc. Novartis AG Pfizer Inc.
Key Topics Covered
1. Report Introduction
2. Brain Hemorrhage Overview
3. Pipeline TherapeuticsAn Overview of Pipeline Products for Brain Hemorrhage
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
7. Therapeutic AssessmentAssessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/9ctcs6/brain_hemorrhage?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005787/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs ,Central Nervous System Drugs ,Hematological Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/11/2018 03:30 PM/DISC: 09/11/2018 03:30 PM